Recombinant Human CSPG3 Protein，GST

CSPG3, or chondroitin sulfate proteoglycan 3, is a member of the lectican family of extracellular matrix proteins, primarily expressed in the central nervous system and various other tissues. It plays a significant role in cell adhesion, proliferation, and migration, contributing to normal developmental processes, extracellular matrix organization, and neuronal function. Research has indicated that CSPG3 may be involved in various pathological conditions, including neurodevelopmental disorders, cancer progression, and tissue repair mechanisms. Due to its unique structure, characterized by a protein core attached to glycosaminoglycan chains, CSPG3 is of particular interest for therapeutic applications and biomolecular studies. The recombinant production of CSPG3 allows for the exploration of its biological functions and interactions in a controlled environment, facilitating studies on its potential roles in disease mechanisms and regenerative medicine. Understanding the detailed properties of CSPG3 through recombinant protein studies may yield insights into its functions and open avenues for novel therapeutic strategies, leveraging its properties for tissue engineering, drug delivery, and innovative treatments in neurobiology and oncology. Additionally, the ability to produce CSPG3 in a recombinant form paves the way for high-throughput screening of binding partners and the development of CSPG3-targeted therapies, underscoring the importance of this research in both fundamental biology and clinical applications.